Filing search / Inhibrx Biosciences, Inc. / "Offset"

8-K

EX-99.1

INBX Inhibrx Biosciences, Inc.

9 May 24

Inhibrx Reports First Quarter 2024 Financial Results

4:08pm

for operations were offset in part by the receipt of $38.7 million in proceeds from the exercise of stock options during the first quarter of 2024

DEFM14A

INBX Inhibrx Biosciences, Inc.

26 Apr 24

Proxy related to merger

4:06pm

% (or such lower rate specified by an applicable income tax treaty), which may be offset by U.S. source capital losses of the Non-U.S. holder (even though

DEFA14A

INBX Inhibrx Biosciences, Inc.

23 Jan 24

Additional proxy soliciting materials

6:38am

of business that does not relate primarily to Taxes) with respect to any material Tax or (6) surrender any right to claim a refund, offset, or other reduction … of its Group to, make any claim, demand or offset, or commence any Proceeding asserting any claim or demand, including any claim of contribution or any

8-K

EX-2.1

krebat0zv2j 67hjbq8n

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

8-K

EX-2.2

5t5 bxqq4n5

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

8-K

EX-99.1

5papxigu5gf

9 Nov 23

Inhibrx Reports Third Quarter 2023 Financial Results

4:03pm

8-K

EX-99.1

yslc3ni2si1hhz0hfrg

7 Aug 23

Inhibrx Reports Second Quarter 2023 Financial Results

4:05pm

DEFA14A

z4nzagc7lbngrf2a

13 Apr 22

Additional proxy soliciting materials

4:09pm

8-K

EX-99.1

ylto4bpkl1eq54wim09

9 Nov 21

Inhibrx Reports Third Quarter 2021 Financial Results

4:37pm